152 related articles for article (PubMed ID: 36531002)
1. Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition
Li S; Hu Y; Liu O; Li X; Lin B
Front Oncol; 2022; 12():1034737. PubMed ID: 36531002
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway.
Zhu J; Zheng Y; Zhang H; Liu Y; Sun H; Zhang P
Am J Transl Res; 2019; 11(6):3862-3878. PubMed ID: 31312395
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
4. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
6. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.
Jin JQ; Han JS; Ha J; Baek HS; Lim DJ
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1095-1110. PubMed ID: 34645125
[TBL] [Abstract][Full Text] [Related]
7. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
9. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
10. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.
Kang L; Zhang ZH; Zhao Y
Am J Transl Res; 2020; 12(12):7870-7884. PubMed ID: 33437366
[TBL] [Abstract][Full Text] [Related]
11. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
12. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract][Full Text] [Related]
13. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
14. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.
Lu Z; Zhu X; Ye Y; Fu H; Mao J
Cytotechnology; 2021 Oct; 73(5):697-713. PubMed ID: 34629746
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer.
Park S; Kwon W; Park JK; Baek SM; Lee SW; Cho GJ; Ha YS; Lee JN; Kwon TG; Kim MO; Ryoo ZY; Han SH; Han JE; Choi SK
Arch Biochem Biophys; 2020 Jul; 688():108407. PubMed ID: 32407712
[TBL] [Abstract][Full Text] [Related]
16. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
[TBL] [Abstract][Full Text] [Related]
17. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
19. Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway.
Kang K; Wang Y
Drug Des Devel Ther; 2019; 13():4451-4460. PubMed ID: 32021086
[TBL] [Abstract][Full Text] [Related]
20. [P38 MAPK signaling pathway mediates advanced oxidation protein product-induced epithelial-to-mesenchymal transition in tubular cells].
Huang LL; Zhu XL; Deng WQ; Duan N; Liang XJ; Wang Y; Guo TT; Shu SS; Xiang XH; Jiang TT; Tang X; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1209-1214. PubMed ID: 27687652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
